Salk Institute for Biological Studies — United States
Medicine · Health Sciences
5h-index431citations13works0.02yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Cell Adhesion Molecules Research(7), Angiogenesis and VEGF in Cancer(4), Cancer Cells and Metastasis(2), Cellular Mechanics and Interactions(2), Chemical Synthesis and Analysis(2)
Publications13 total
Nature Methods·2020· 68 citedOpen Access
Figshare·2020Open Access
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
Developmental Cell·2019· 50 citedOpen Access
eLife·2016· 170 citedOpen Access
Journal of Translational Medicine·2007· 79 citedOpen Access
European Journal of Cancer Supplements·2007
Investigational New Drugs·2007· 62 cited
M200 (volociximab), a chimeric antibody against integrin alpha5 beta1, inhibits tumor growth by multiple mechanisms
Cancer Research·2005
F200, a Fab Derivative of M200 (Volociximab; Anti–A5ß1), Is a Potent Inhibitor of Angiogenesis in a Rabbit Model of Choroidal Neovascularization
2005
Journal of Immunotherapy·2004· 2 cited
Frequent Co-authors
Vinay Bhaskar(6), Melvin Fox(4), Melanie Wong(3), Robert B. DuBridge(3), Vanitha Ramakrishnan(3), Cara R. Schiavon(3), Jasmine W. Feng(3), Omar A. Quintero(3), Uri Manor(3), Danna Breinberg(3), Christian Schuberth(2), Roland Aufschnaiter(2), Johannes Fels(2), Ireth García-Aguilar(2), Annette Janning(2), C. P. Dlugos(2), Marco Schäfer‐Herte(2), Christoph Klingner(2), Mike Wälte(2), Julian Kuhlmann(2)